Celltrion Healthcare decides to launch Remsima with Pfizer on November

Celltrion Healthcare announced it confirmed the release of Remsima(U.S. product name: Inflectra) with the U.S. exclusive distribution partnering company Pfizer in the world’s largest biomedicine market, the U.S., on November.

Celltrion Healthcare continuously made discussions about the sales strategy for the U.S. market with Pfizer which has the U.S. exclusive sales license of Remsima after it...